n,n-dimethylarginine has been researched along with Shock, Septic in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (25.00) | 29.6817 |
| 2010's | 9 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Garred, P; Hansen, MB; Hedegaard, ER; Hyldegaard, O; Madsen, MB; Perner, A; Pilely, K; Rasmussen, LS; Simonsen, U; Wahl, AM | 1 |
| Coskun, CN; Demirel-Yilmaz, E; Savci, V; Usanmaz, SE | 1 |
| Gordon, AC; Lambden, S; Leiper, J; Piper, S; Tomlinson, J | 1 |
| Caddick, S; Dyson, A; Lambden, S; Leiper, J; McDonald, N; Nandi, M; Singer, M; Sujkovic, E; Taylor, V; Tomlinson, J; Wang, Z | 1 |
| Aydemir, O; Bas, AY; Demirel, N; Ozcan, B; Yucel, H | 1 |
| Bestle, MH; Haase, N; Itenov, TS; Johansson, PI; Mortensen, KM; Müller, RB; Olsen, NV; Ostrowski, SR; Perner, A; Søe-Jensen, P | 1 |
| Hämäläinen, S; Jantunen, E; Juutilainen, A; Koivula, I; Lappalainen, M; Pulkki, K | 1 |
| Adachi, H; Fujiwara, N; Kawagoe, Y; Matsui, T; Nakamura, T; Okuda, S; Sato, E; Shoji, H; Suzuki, T; Takeuchi, M; Ueda, S; Ueda, Y; Yamada, S; Yamagishi, S | 1 |
| Haymond, S; Jennings, L; Wainwright, MS; Weiss, SL; Yu, M; Zhang, G | 1 |
| Bierhaus, A; Brenner, T; Bruckner, T; Fleming, TH; Hofer, S; Krauser, U; Martin, E; Mieth, M; Nawroth, PP; Rosenhagen, C; Weigand, MA | 1 |
| Crowley, V; Dempsey, F; Kelleher, DP; McManus, R; O'Dwyer, MJ; Ryan, T | 1 |
| Böger, RH | 1 |
2 trial(s) available for n,n-dimethylarginine and Shock, Septic
| Article | Year |
|---|---|
Associations of Plasma Nitrite, L-Arginine and Asymmetric Dimethylarginine With Morbidity and Mortality in Patients With Necrotizing Soft Tissue Infections.
Topics: Adult; Aged; Arginine; Biomarkers; Disease-Free Survival; Female; Hospital Mortality; Humans; Male; Middle Aged; Nitrites; Prospective Studies; Severity of Illness Index; Shock, Septic; Soft Tissue Infections; Survival Rate; Time Factors | 2018 |
Asymmetric dimethylarginine and L-arginine levels in neonatal sepsis and septic shock.
Topics: Arginine; Biomarkers; Case-Control Studies; Female; Humans; Infant, Newborn; Male; Multiple Organ Failure; Prognosis; Prospective Studies; Sepsis; Severity of Illness Index; Shock, Septic | 2015 |
10 other study(ies) available for n,n-dimethylarginine and Shock, Septic
| Article | Year |
|---|---|
Time-Dependent Production of Endothelium-Related Biomarkers is Affected Differently in Hemorrhagic and Septic Shocks.
Topics: Animals; Antioxidants; Arginine; Biomarkers; Blood Pressure; Disease Models, Animal; Endothelial Cells; Hydrogen Sulfide; Male; Nitric Oxide; Rats, Wistar; Resuscitation; Shock, Hemorrhagic; Shock, Septic; Time Factors | 2018 |
Evidence for a protective role for the rs805305 single nucleotide polymorphism of dimethylarginine dimethylaminohydrolase 2 (DDAH2) in septic shock through the regulation of DDAH activity.
Topics: Amidohydrolases; Arginine; Biomarkers; Humans; Organ Dysfunction Scores; Polymorphism, Single Nucleotide; Protective Agents; Shock, Septic; Statistics, Nonparametric; Time Factors | 2018 |
Pharmacological inhibition of DDAH1 improves survival, haemodynamics and organ function in experimental septic shock.
Topics: Amidohydrolases; Animals; Arginine; Endotoxemia; Enzyme Inhibitors; Fluid Therapy; Hemodynamics; Macrophages, Peritoneal; Male; Norepinephrine; Peritonitis; Rats; Rats, Wistar; Shock, Septic | 2014 |
High Levels of Methylarginines Were Associated With Increased Mortality in Patients With Severe Sepsis.
Topics: Aged; Arginine; Female; Humans; Male; Middle Aged; Nitric Oxide; Proportional Hazards Models; Sepsis; Shock, Septic | 2016 |
Asymmetric dimethylarginine in the assessment of febrile neutropenia in hematological patients.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Arginine; Bacteremia; Biomarkers; C-Reactive Protein; Febrile Neutropenia; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Prospective Studies; Shock, Septic; Stem Cell Transplantation; Transplantation, Autologous | 2017 |
Circulating levels of advanced glycation end products (AGE) and interleukin-6 (IL-6) are independent determinants of serum asymmetric dimethylarginine (ADMA) levels in patients with septic shock.
Topics: Aged; Arginine; Biomarkers; Female; Glycation End Products, Advanced; Humans; Interleukin-6; Male; Middle Aged; Shock, Septic | 2009 |
Pilot study of the association of the DDAH2 -449G polymorphism with asymmetric dimethylarginine and hemodynamic shock in pediatric sepsis.
Topics: Adolescent; Amidohydrolases; Arginine; Base Sequence; Child; DNA Primers; Genetic Association Studies; Genotype; Hemodynamics; Humans; Molecular Sequence Data; Nitric Oxide; Pilot Projects; Polymorphism, Single Nucleotide; Prospective Studies; Racial Groups; Sequence Analysis, DNA; Sex Factors; Shock, Septic; Tandem Mass Spectrometry | 2012 |
L-arginine and asymmetric dimethylarginine are early predictors for survival in septic patients with acute liver failure.
Topics: Aged; Arginine; Enzyme-Linked Immunosorbent Assay; Female; Humans; Liver Failure, Acute; Male; Middle Aged; Multiple Organ Failure; Nitric Oxide; ROC Curve; Sepsis; Shock, Septic; Time Factors; Treatment Outcome | 2012 |
Septic shock is correlated with asymmetrical dimethyl arginine levels, which may be influenced by a polymorphism in the dimethylarginine dimethylaminohydrolase II gene: a prospective observational study.
Topics: Alleles; Amidohydrolases; Arginine; Female; Genetic Variation; Humans; Male; Polymorphism, Genetic; Prospective Studies; Shock, Septic | 2006 |
Live and let die: asymmetric dimethylarginine and septic shock.
Topics: Arginine; Critical Illness; Humans; Nitric Oxide; Nitric Oxide Synthase; Shock, Septic | 2006 |